Reduced wear in vitamin E-infused highly cross-linked polyethylene cups: 5-year results of a randomized controlled trial.


Journal

Acta orthopaedica
ISSN: 1745-3682
Titre abrégé: Acta Orthop
Pays: Sweden
ID NLM: 101231512

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 3 12 2020
medline: 16 6 2021
entrez: 2 12 2020
Statut: ppublish

Résumé

Background and purpose - Vitamin E-infused polyethylene is a relatively new material in joint arthroplasty; there are no long-term reports, and only few mid-term results. Using radiostereometric analysis (RSA), we primarily determined whether vitamin E-infused highly cross-linked polyethylene (HXLPE/VitE) acetabular cups show less wear than ultra-high molecular weight polyethylene (UHMWPE) acetabular cups at 5 years after total hip arthroplasty (THA). We also assessed whether wear rates correlate with increasing cup inclination angles or cup sizes.Patients and methods - This is a 5-year follow-up of our previously reported randomized controlled trial of 62 patients with 3 years' follow-up, who received THA with either an HXLPE/VitE or a UHMWPE acetabular cup. At 5 years, 40 patients were analyzed (22 in the HXLPE/VitE and 18 in the UHMWPE group).Results - HXLPE/VitE cups continued to show less cumulative femoral head penetration than UHMWPE cups (HXLPE/VitE: 0.24 mm, UHMWPE: 0.45 mm; p < 0.001). Distribution of wear was also more even with HXLPE/VitE cups than with UHMWPE cups (p = 0.002). Moreover, the difference in PE wear between 1 and 5 years in both groups showed no statistically significant correlation with increasing cup inclination angles or cup sizes. Finally, no osteolysis and implant loosening occurred, and no revision surgeries were required.Interpretation - Wear rates continue to be lower in HXLPE/VitE cups than in UHMWPE cups at 5 years of follow-up without correlation with increasing cup inclination angles or cup sizes. Finally, HXLPE/VitE cups may have the potential to prevent osteolysis and implant loosening.

Identifiants

pubmed: 33263447
doi: 10.1080/17453674.2020.1852785
pmc: PMC8158183
doi:

Substances chimiques

Polyethylenes 0
ultra-high molecular weight polyethylene 0
Vitamin E 1406-18-4
Polyethylene 9002-88-4

Banques de données

ClinicalTrials.gov
['NCT02524587']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-155

Références

Int Orthop. 2015 Aug;39(8):1499-505
pubmed: 25631687
Proc Inst Mech Eng H. 2018 Aug;232(8):753-758
pubmed: 29956565
J Biomed Mater Res B Appl Biomater. 2014 Nov;102(8):1627-38
pubmed: 24652696
World J Orthop. 2015 Mar 18;6(2):172-89
pubmed: 25793158
Hip Int. 2015 Jan-Feb;25(1):50-5
pubmed: 25633755
J Biomech. 2005 Apr;38(4):893-901
pubmed: 15713311
Bone Joint J. 2018 Jul;100-B(7):891-897
pubmed: 29954202
J Bone Joint Surg Am. 2000 Aug;82(8):1102-7
pubmed: 10954099
Orthopade. 2020 Dec;49(12):1077-1085
pubmed: 31696260
Orthop Traumatol Surg Res. 2010 Oct;96(6):609-15
pubmed: 20655819
Biomaterials. 2007 Dec;28(35):5225-37
pubmed: 17881049
J Arthroplasty. 2002 Aug;17(5):649-61
pubmed: 12168184
Bone Joint J. 2017 May;99-B(5):577-584
pubmed: 28455465
Biomaterials. 2005 Nov;26(33):6657-63
pubmed: 15993487
Acta Orthop. 2015 Apr;86(2):159-68
pubmed: 25301435
J Bone Joint Surg Am. 2018 Jan 17;100(2):107-114
pubmed: 29342060
Clin Orthop Relat Res. 2013 Nov;471(11):3596-600
pubmed: 23893361
J Arthroplasty. 2016 Jun;31(6):1251-1255
pubmed: 26777551
J Bone Joint Surg Am. 2015 Aug 19;97(16):1366-71
pubmed: 26290088
J Arthroplasty. 1994 Apr;9(2):119-25
pubmed: 8014641
J Arthroplasty. 2015 Jul;30(7):1260-4
pubmed: 25754257
Surg Technol Int. 2015 Nov;27:263-7
pubmed: 26680408
J Clin Orthop Trauma. 2018 Apr-Jun;9(2):133-136
pubmed: 29896015
Clin Orthop Relat Res. 2009 Nov;467(11):2895-900
pubmed: 19412648
Int Orthop. 2017 Jun;41(6):1113-1118
pubmed: 27815591
Bone Joint J. 2019 Jul;101-B(7):760-767
pubmed: 31256674
Hip Int. 2017 Jul 25;27(4):368-372
pubmed: 28106229
J Bone Joint Surg Br. 1998 Mar;80(2):345-50
pubmed: 9546474
Orthop Surg. 2017 May;9(2):186-190
pubmed: 28557297
Hip Int. 2016 Jan-Feb;26(1):97-103
pubmed: 26692248
J Bone Joint Surg Am. 2017 Sep 6;99(17):1447-1452
pubmed: 28872526

Auteurs

Goulven Rochcongar (G)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Matthieu Remazeilles (M)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Emeline Bourroux (E)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Julien Dunet (J)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Valentin Chapus (V)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Matthieu Feron (M)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

César Praz (C)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Geoffrey Buia (G)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Christophe Hulet (C)

Caen Normandy University Hospital Centre, Department of Orthopaedic and Trauma Surgery, 14000, Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH